Marine Antimicrobial Peptides and Marine Compounds for Fighting Antimicrobial Resistance
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 June 2022) | Viewed by 7290
Special Issue Editor
Special Issue Information
Dear Colleagues,
A rapid development in the discovery of antimicrobial peptides (AMPs) can be seen, which are used alone or in combination with antibiotics for synergetic and efficient action against microbial infections. AMPs are short-chain polypeptides with less than 50 amino acids and are amphipathic in nature. Most AMPs are neither limited to a single pathogen nor to a single mode of antimicrobial action, and they show multiple modes of action, such as disruption of membrane and metabolic inhibition of DNA, RNA, protein synthesis, and bacterial wall synthesis. Apart from acting as antimicrobial agents, AMPs show different functions, such as antitumor, anti-inflammatory, wound-healing, and detoxification effects. Hence, it is challenging for pathogens to develop resistance against AMPs. For these reasons, AMPs could be used to solve the global problem of antibiotic-resistant microbial infections.
Marine AMPs are considered as one of the most promising molecular classes for the development of alternatives to antibiotics. Marine invertebrates, fish and microorganisms are the sources of discovery of novel antimicrobial peptides with unique structure and function. At present, many antimicrobial peptides have been isolated from Marine invertebrates, including cnidarians, mollusks, annelids, crustaceans, echinoderms and protozoans, as well as vertebrate fish.
In this Special Issue, we are aiming to collect original research papers that focusing on isolation, purification, synthesis of Marine-derived AMPs and other antibacterial compounds from marine organism. New discoveries of marine AMPs will be particularly exciting to readers and editors, and we are very grateful for your submission. We hope that this special issue can serve as a platform for the exchange of research results, and hope that the included research articles will help promote the development and application of marine AMPs.
Dr. Ilson Whang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
